+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

AI-Enabled Drug Discovery and Clinical Trials Market Report 2023-2033

  • PDF Icon

    Report

  • 267 Pages
  • June 2023
  • Region: Global
  • Visiongain
  • ID: 5847198
Description Jump to:
Overall world revenue for AI-Enabled Drug Discovery and Clinical Trials Market, 2023 to 2033 in terms of value will surpass US$2.18 billion in 2023. The publisher predicts strong revenue growth through to 2033. This work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

The AI-Enabled Drug Discovery and Clinical Trials Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Growing Awareness of AI applications in Healthcare is Boosting the Market Growth

With the rise of AI applications in healthcare services, people’s awareness and acceptance of AI-enabled solutions have grown. More pharmaceutical companies are, therefore, seeking to incorporate these solutions into their drug discovery and clinical trial processes. AI-based drug delivery solutions are becoming increasingly popular in the pharmaceutical industry. These solutions involve using artificial intelligence technologies to develop more efficient and effective drug delivery methods. The use of AI in drug delivery has the potential to transform the industry by reducing costs, improving drug efficacy and safety, and providing better patient outcomes.

The market for AI-based drug delivery solutions is expected to grow in the coming years, with a number of companies already offering or developing such solutions. Some of the key players in this market include:
  • Novartis - Novartis is one of the leading players in the AI-based drug delivery market, with a focus on developing smart inhalers to treat respiratory diseases.
  • Medtronic - Medtronic is a medical devices company that is building an AI-based drug delivery platform to improve the delivery of insulin for diabetic patients.
  • Insilico Medicine - Insilico Medicine is a drug discovery company that is using AI to develop new drugs and drug delivery methods.
  • Johnson & Johnson - Johnson & Johnson is using AI to develop personalized drug delivery solutions, including smart drug-infused contact lenses and implantable drug delivery devices.
  • GSK - GSK is using AI to develop inhalers that can adjust the dosage based on the patient's breathing pattern.
As the competition between market players intensifies, companies are investing heavily in research and development to stay ahead of the curve. This is driving innovation and pushing the boundaries of what is possible in the drug delivery industry. In the future, AI-based drug delivery solutions are likely to become increasingly sophisticated, personalized, and targeted, improving patient outcomes and transforming the pharmaceutical industry.

Lack of Skilled Personnel to Hinder the Market Growth

Patient safety is a significant challenge during the drug discovery phase, as activities involving the interpretation of drug effects and anticipation of potential side effects can pose a major constraint on the market. Additionally, the lack of skilled personnel and inadequate datasets for drug discovery and development are crucial factors that may impact market growth. The implementation of AI systems in drug discovery requires companies to possess expertise in system design, management, and implementation. Given the complexity of AI, personnel working with these systems need to have a deep understanding of technologies such as machine learning, deep learning, and other aspects of artificial intelligence. Integrating AI technologies into existing systems to replicate human brain behaviour necessitates substantial data processing. AI/ML development is being restricted owing to lack of professional standards and certifications.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the AI-enabled drug discovery and clinical trials market evolving?
  • What is driving and restraining the AI-enabled drug discovery and clinical trials market?
  • How will each AI-enabled drug discovery and clinical trials submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
  • How will the market shares for each AI-enabled drug discovery and clinical trials submarket develop from 2023 to 2033?
  • What will be the main driver for the overall market from 2023 to 2033?
  • Will leading AI-enabled drug discovery and clinical trials markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the AI-enabled drug discovery and clinical trials projects for these leading companies?
  • How will the industry evolve during the period between 2023 and 2033? What are the implications of AI-enabled drug discovery and clinical trials projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the AI-enabled drug discovery and clinical trials market?
  • Where is the AI-enabled drug discovery and clinical trials market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the AI-enabled drug discovery and clinical trials market today, and over the next 10 years:

  • The 267-page report provides 102 tables and 151 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them - NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the AI-enabled drug discovery and clinical trials market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2033, this new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising AI-enabled drug discovery and clinical trials prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Component Outlook

  • Services
  • Software

Application

  • Clinical Trials
  • Drug Design
  • Data Aggregation and Analysis
  • Drug Characterization
  • Biomarker Research
  • Others

Therapeutic Area

  • Oncology
  • Cardiovascular Diseases
  • Infectious Diseases
  • Neurodegenerative Diseases
  • Metabolic Diseases
  • Others

End-user

  • Pharmaceutical & Biopharmaceutical Companies
  • Contract Research Organizations (CROs)
  • Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 18 leading national markets:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Russia
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Rest of MEA
The report also includes profiles and for some of the leading companies in the AI-Enabled Drug Discovery and Clinical Trials Market, 2023 to 2033, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth

  • AbbVie Inc.
  • Exscientia
  • GNS Healthcare
  • IBM Watson
  • Merck & Co., Inc.
  • Novartis AG
  • PathAI
  • Saama Technologies
  • Unlearn.AI, Inc.

How will the AI-Enabled Drug Discovery and Clinical Trials Market, 2023 to 2033 report help you?

In summary, the 260+ page report provides you with the following knowledge:
  • Revenue forecasts to 2033 for AI-Enabled Drug Discovery and Clinical Trials Market, 2023 to 2033 Market, with forecasts for component, application, therapeutic area, and end-user, each forecast at a global and regional level - discover the industry’s prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2033 for five regional and 18 key national markets - See forecasts for the AI-Enabled Drug Discovery and Clinical Trials Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 9 of the major companies involved in the AI-Enabled Drug Discovery and Clinical Trials Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only this report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With this new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how the work could benefit your research, analyses, and decisions. The study is for everybody needing commercial analyses for the AI-Enabled Drug Discovery and Clinical Trials Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to AI-Enabled Drug Discovery and Clinical Trials Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Reports
1.10 About
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Growing Demand for Personalized Medicine
3.2.1.2 Advancements in Technology
3.2.1.3 Growing Awareness of AI in Healthcare
3.2.1.4 Cost-effectiveness of AI-enabled Solutions
3.2.2 Market Restraining Factors
3.2.2.1 Lack of Skilled Personnel to Hamper the Market Growth
3.2.2.2 Limited Data Availability is a Major Challenge in Adoption of AI-enabled Solutions
3.2.2.3 Challenges Associated with Integration of New AI-enabled Solution with Existing Infrastructure
3.2.2.4 Ethics and Data Privacy Issues Hindering the Market Growth
3.2.2.5 Regulatory Hurdles Restraining the Global Market Growth
3.2.3 Market Opportunities
3.2.3.1 Improved Patient Outcomes
3.2.3.2 Increased Adoption Of AI-Enabled Solution By Pharma & Biopharma Companies For Clinical Trials
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
4 AI-Enabled Drug Discovery and Clinical Trials Market Analysis by Components
4.1 Key Findings
4.2 Components Segment: Market Attractiveness Index
4.3 AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Components
4.4 Services
4.4.1 Market Size by Region, 2023-2033 (US$ Million)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.5 Software Solutions
4.5.1 Market Size by Region, 2023-2033 (US$ Million)
4.5.2 Market Share by Region, 2023 & 2033 (%)
5 AI-Enabled Drug Discovery and Clinical Trials Market Analysis by Application
5.1 Key Findings
5.2 Application Segment: Market Attractiveness Index
5.3 AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Application
5.4 Clinical Trials
5.4.1 Market Size by Region, 2023-2033 (US$ Million)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Drug Design
5.5.1 Market Size by Region, 2023-2033 (US$ Million)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Data Aggregation and Analysis
5.6.1 Market Size by Region, 2023-2033 (US$ Million)
5.6.2 Market Share by Region, 2023 & 2033 (%)
5.7 Drug Characterization
5.7.1 Market Size by Region, 2023-2033 (US$ Million)
5.7.2 Market Share by Region, 2023 & 2033 (%)
5.8 Biomarker Research
5.8.1 Market Size by Region, 2023-2033 (US$ Million)
5.8.2 Market Share by Region, 2023 & 2033 (%)
5.9 Others
5.9.1 Market Size by Region, 2023-2033 (US$ Million)
5.9.2 Market Share by Region, 2023 & 2033 (%)
6 AI-Enabled Drug Discovery and Clinical Trials Market Analysis by Therapeutic Area
6.1 Key Findings
6.2 Therapeutic Area Segment: Market Attractiveness Index
6.3 AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Therapeutic Area
6.4 Oncology
6.4.1 Market Size by Region, 2023-2033 (US$ Million)
6.4.2 Market Share by Region, 2023 & 2033 (%)
6.5 Cardiovascular Diseases
6.5.1 Market Size by Region, 2023-2033 (US$ Million)
6.5.2 Market Share by Region, 2023 & 2033 (%)
6.6 Infectious Diseases
6.6.1 Market Size by Region, 2023-2033 (US$ Million)
6.6.2 Market Share by Region, 2023 & 2033 (%)
6.7 Neurodegenerative Diseases
6.7.1 Market Size by Region, 2023-2033 (US$ Million)
6.7.2 Market Share by Region, 2023 & 2033 (%)
6.8 Metabolic Diseases
6.8.1 Market Size by Region, 2023-2033 (US$ Million)
6.8.2 Market Share by Region, 2023 & 2033 (%)
6.9 Others
6.9.1 Market Size by Region, 2023-2033 (US$ Million)
6.9.2 Market Share by Region, 2023 & 2033 (%)
7 AI-Enabled Drug Discovery and Clinical Trials Market Analysis by End-User
7.1 Key Findings
7.2 End-User Segment: Market Attractiveness Index
7.3 AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by End-User
7.4 Pharmaceutical & Biopharmaceutical Companies
7.4.1 Market Size by Region, 2023-2033 (US$ Million)
7.4.2 Market Share by Region, 2023 & 2033 (%)
7.5 Contract Research Organizations (CROs)
7.5.1 Market Size by Region, 2023-2033 (US$ Million)
7.5.2 Market Share by Region, 2023 & 2033 (%)
7.6 Others
7.6.1 Market Size by Region, 2023-2033 (US$ Million)
7.6.2 Market Share by Region, 2023 & 2033 (%)
8 AI-Enabled Drug Discovery and Clinical Trials Market Analysis by Region
8.1 Key Findings
8.2 Regional Market Size Estimation and Forecast
9 North America AI-Enabled Drug Discovery and Clinical Trials Market Analysis
9.1 Key Findings
9.2 North America AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
9.3 North America AI-Enabled Drug Discovery and Clinical Trials Market by Country, 2023, 2028 & 2033 (US$ Million)
9.4 North America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Country
9.5 North America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Components
9.6 North America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Application
9.7 North America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Therapeutic Area
9.8 North America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by End-user
9.9 U.S. AI-Enabled Drug Discovery and Clinical Trials Market Analysis
9.10 Canada AI-Enabled Drug Discovery and Clinical Trials Market Analysis
10 Europe AI-Enabled Drug Discovery and Clinical Trials Market Analysis
10.1 Key Findings
10.2 Europe AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
10.3 Europe AI-Enabled Drug Discovery and Clinical Trials Market by Country, 2023, 2028 & 2033 (US$ Million)
10.4 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Country
10.5 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Components
10.6 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Application
10.7 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Therapeutic Area
10.8 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by End-user
10.9 Germany AI-Enabled Drug Discovery and Clinical Trials Market Analysis
10.10 UK AI-Enabled Drug Discovery and Clinical Trials Market Analysis
10.11 France AI-Enabled Drug Discovery and Clinical Trials Market Analysis
10.12 Italy AI-Enabled Drug Discovery and Clinical Trials Market Analysis
10.13 Spain AI-Enabled Drug Discovery and Clinical Trials Market Analysis
10.14 Russia AI-Enabled Drug Discovery and Clinical Trials Market Analysis
10.15 Rest of Europe AI-Enabled Drug Discovery and Clinical Trials Market Analysis
11 Asia AI-Enabled Drug Discovery and Clinical Trials Market Analysis
11.1 Key Findings
11.2 Asia AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
11.3 Asia AI-Enabled Drug Discovery and Clinical Trials Market by Country, 2023, 2028 & 2033 (US$ Million)
11.4 Asia AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Country
11.5 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Components
11.6 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Application
11.7 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Therapeutic Area
11.8 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by End-user
11.9 Japan AI-Enabled Drug Discovery and Clinical Trials Market Analysis
11.10 China AI-Enabled Drug Discovery and Clinical Trials Market Analysis
11.11 India AI-Enabled Drug Discovery and Clinical Trials Market Analysis
11.12 Australia AI-Enabled Drug Discovery and Clinical Trials Market Analysis
11.13 South Korea AI-Enabled Drug Discovery and Clinical Trials Market Analysis
11.14 Rest of Asia AI-Enabled Drug Discovery and Clinical Trials Market Analysis
12 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Analysis
12.1 Key Findings
12.2 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
12.3 Latin America AI-Enabled Drug Discovery and Clinical Trials Market by Country, 2023, 2028 & 2033 (US$ Million)
12.4 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Country
12.5 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Components
12.6 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Application
12.7 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Therapeutic Area
12.8 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by End-user
12.9 Brazil AI-Enabled Drug Discovery and Clinical Trials Market Analysis
12.10 Mexico AI-Enabled Drug Discovery and Clinical Trials Market Analysis
12.11 Argentina AI-Enabled Drug Discovery and Clinical Trials Market Analysis
12.12 Rest of Latin America AI-Enabled Drug Discovery and Clinical Trials Market Analysis
13 MEA AI-Enabled Drug Discovery and Clinical Trials Market Analysis
13.1 Key Findings
13.2 MEA AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
13.3 MEA AI-Enabled Drug Discovery and Clinical Trials Market by Country, 2023, 2028 & 2033 (US$ Million)
13.4 MEA AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Country
13.5 MEA AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Components
13.6 MEA AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Application
13.7 MEA AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Therapeutic Area
13.8 MEA AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by End-user
13.9 GCC AI-Enabled Drug Discovery and Clinical Trials Market Analysis
13.10 South Africa AI-Enabled Drug Discovery and Clinical Trials Market Analysis
13.11 Rest of MEA AI-Enabled Drug Discovery and Clinical Trials Market Analysis
14 Company Profiles
14.1 Company Share Analysis, 2022
14.2 Strategic Outlook
14.3 IBM Watson
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.3.1 Net Revenue, 2019 -2022
14.3.3.2 R&D, 2019-2022
14.3.3.3 Regional Market Shares, 2022
14.3.4 Service Benchmarking
14.3.5 Strategic Outlook
14.4 Saama Technologies
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Service Benchmarking
14.4.4 Strategic Outlook
14.5 PathAI
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Service Benchmarking
14.5.4 Strategic Outlook
14.6 GNS Healthcare
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Service Benchmarking
14.6.4 Strategic Outlook
14.7 Unlearn.AI, Inc.
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Service Benchmarking
14.7.4 Strategic Outlook
14.8 Novartis AG
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Financial Analysis
14.8.3.1 Net Revenue, 2020 -2022
14.8.4 Service Benchmarking
14.8.5 Strategic Outlook
14.9 Merck & Co., Inc.
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Financial Analysis
14.9.3.1 Net Revenue, 2019-2021
14.9.4 Service Benchmarking
14.9.5 Strategic Outlook
14.10 AbbVie Inc.
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Financial Analysis
14.10.3.1 Net Revenue, 2019-2021
14.10.4 Service Benchmarking
14.10.5 Strategic Outlook
14.11 Exscientia
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Service Benchmarking
14.11.4 Strategic Outlook
15 Conclusion and Recommendations
15.1 Concluding Remarks
15.2 Recommendations for Market Players
List of Tables
Table 1 AI-Enabled Drug Discovery and Clinical Trials Market Snapshot, 2023 & 2033 (US$ Million, CAGR %)
Table 2 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): “V” Shaped Recovery
Table 3 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): “U” Shaped Recovery
Table 4 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): “W” Shaped Recovery
Table 5 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): “L” Shaped Recovery
Table 6 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Components, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 7 Services Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 8 Software Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 9 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 10 Clinical Trials Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 11 Drug Design Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 12 Data Aggregation and Analysis Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 13 Drug Characterization Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 14 Biomarker Research Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 15 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 16 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 17 Oncology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 18 Cardiovascular Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 19 Infectious Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 20 Neurodegenerative Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 21 Metabolic Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 22 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 23 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-User, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 24 Pharmaceutical & Biopharmaceutical Companies Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 25 Contract Research Organizations (CROs) Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 26 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 27 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 28 North America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 29 North America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Components, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 30 North America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 31 North America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 32 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-User, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 33 U.S. AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 34 Canada AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 35 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 36 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Components, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 37 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 38 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 39 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-User, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 40 Germany AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 41 UK AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 42 France AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 43 Italy AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 44 Spain AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 45 Russia AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 46 Rest of Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 47 Asia AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 48 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Components, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 49 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 50 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 51 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-User, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 52 Japan AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 53 China AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 54 India AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 55 Australia AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 56 South Korea AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 57 Rest of Asia AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 58 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 59 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Components, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 60 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 61 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 62 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-User, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 63 Brazil AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 64 Mexico AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 65 Argentina AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 66 Rest of Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 67 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 68 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Components, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 69 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 70 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 71 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-User, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 72 GCC AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 73 South Africa AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 74 Rest of MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 75 Strategic Outlook
Table 76 IBM Watson: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 77 IBM: Service Benchmarking
Table 78 IBM: Strategic Outlook
Table 79 Saama Technologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 80 Saama Technologies: Service Benchmarking
Table 81 Saama Technologies: Strategic Outlook
Table 82 PathAI: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 83 PathAI: Service Benchmarking
Table 84 PathAI: Strategic Outlook
Table 85 GNS Healthcare: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 GNS Healthcare: Service Benchmarking
Table 87 GNS Healthcare: Strategic Outlook
Table 88 Unlearn.AI: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 Unlearn.AI: Service Benchmarking
Table 90 Unlearn.AI: Strategic Outlook
Table 91 Novartis: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 Novartis: Service Benchmarking
Table 93 Novartis: Strategic Outlook
Table 94 Merck & Co., Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 Merck & Co. Inc.: Service Benchmarking
Table 96 Novartis: Strategic Outlook
Table 97 Abbvie Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 AbbVie Inc.: Service Benchmarking
Table 99 Exscientia: Strategic Outlook
Table 100 Exscientia: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 Exscientia: Service Benchmarking
Table 102 Exscientia: Strategic Outlook
List of Figures
Figure 1 AI-Enabled Drug Discovery and Clinical Trials Market Segmentation
Figure 2 AI-Enabled Drug Discovery and Clinical Trials Market by Component: Market Attractiveness Index
Figure 3 AI-Enabled Drug Discovery and Clinical Trials Market by Application: Market Attractiveness Index
Figure 4 AI-Enabled Drug Discovery and Clinical Trials Market by Therapeutic Area Market Attractiveness Index
Figure 5 AI-Enabled Drug Discovery and Clinical Trials Market by End-user: Market Attractiveness Index
Figure 6 AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index by Region
Figure 7 AI-Enabled Drug Discovery and Clinical Trials Market: Market Dynamics
Figure 8 AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2023-2033 (US$ Million, AGR %): “V” Shaped Recovery
Figure 9 AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2023-2033 (US$ Million, AGR %): “U” Shaped Recovery
Figure 10 AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2023-2033 (US$ Million, AGR %): “W” Shaped Recovery
Figure 11 AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2023-2033 (US$ Million, AGR %): “L” Shaped Recovery
Figure 12 AI-Enabled Drug Discovery and Clinical Trials Market: Porter’s Five Forces Analysis
Figure 13 AI-Enabled Drug Discovery and Clinical Trials Market: PEST Analysis
Figure 14 AI-Enabled Drug Discovery and Clinical Trials Market by Components: Market Attractiveness Index
Figure 15 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Components, 2023-2033 (US$ Million, AGR %)
Figure 16 AI-Enabled Drug Discovery and Clinical Trials Share Forecast by Components, 2023, 2028, 2033 (%)
Figure 17 Services Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 18 Services Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 19 Software Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 20 Software Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 21 AI-Enabled Drug Discovery and Clinical Trials Market by Application: Market Attractiveness Index
Figure 22 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 23 AI-Enabled Drug Discovery and Clinical Trials Share Forecast by Application, 2023, 2028, 2033 (%)
Figure 24 Clinical Trials Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 25 Clinical Trials Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 26 Drug Design Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 27 Drug Design Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 28 Data Aggregation and Analysis Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 29 Data Aggregation and Analysis Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 30 Drug Characterization Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 31 Drug Characterization Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 32 Biomarker Research Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 33 Biomarker Research Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 34 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 35 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 36 AI-Enabled Drug Discovery and Clinical Trials Market by Therapeutic Area: Market Attractiveness Index
Figure 37 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR %)
Figure 38 AI-Enabled Drug Discovery and Clinical Trials Share Forecast by Therapeutic Area, 2023, 2028, 2033 (%)
Figure 39 Oncology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 40 Oncology Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 41 Cardiovascular Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 42 Cardiovascular Diseases Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 43 Infectious Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 44 Infectious Diseases Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 45 Neurodegenerative Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 46 Neurodegenerative Diseases Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 47 Metabolic Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 48 Metabolic Diseases Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 49 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 50 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 51 AI-Enabled Drug Discovery and Clinical Trials Market by End-User: Market Attractiveness Index
Figure 52 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-User, 2023-2033 (US$ Million, AGR %)
Figure 53 AI-Enabled Drug Discovery and Clinical Trials Share Forecast by End-User, 2023, 2028, 2033 (%)
Figure 54 Pharmaceutical & Biopharmaceutical Companies Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 55 Pharmaceutical & Biopharmaceutical Companies Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 56 Contract Research Organizations (CROs) Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 57 Contract Research Organizations (CROs) Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 58 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 59 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 60 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Region 2023 and 2033 (Revenue, CAGR%)
Figure 61 AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Region 2023, 2028, 2033 (%)
Figure 62 AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2023-2033 (US$ Million, AGR %)
Figure 63 North America AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
Figure 64 North America AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 65 North America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 66 North America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
Figure 67 North America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Components, 2023-2033 (US$ Million, AGR %)
Figure 68 North America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Components, 2023 & 2033 (%)
Figure 69 North America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 70 North America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Application, 2023 & 2033 (%)
Figure 71 North America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR %)
Figure 72 North America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 73 North America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-user, 2023-2033 (US$ Million, AGR %)
Figure 74 North America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by End-user, 2023 & 2033 (%)
Figure 75 U.S. AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 76 Canada AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 77 Europe AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
Figure 78 Europe AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 79 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 80 Europe AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
Figure 81 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Components, 2023-2033 (US$ Million, AGR %)
Figure 82 Europe AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Components, 2023 & 2033 (%)
Figure 83 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 84 Europe AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Application, 2023 & 2033 (%)
Figure 85 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR %)
Figure 86 Europe AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 87 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-user, 2023-2033 (US$ Million, AGR %)
Figure 88 Europe AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by End-user, 2023 & 2033 (%)
Figure 89 Germany AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 90 UK AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 91 France AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 92 Italy AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 93 Spain AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 94 Russia AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 95 Rest of Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 96 Asia AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
Figure 97 Asia AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 98 Asia AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 99 Asia AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
Figure 100 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Components, 2023-2033 (US$ Million, AGR %)
Figure 101 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Components, 2023 & 2033 (%)
Figure 102 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 103 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Application, 2023 & 2033 (%)
Figure 104 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR %)
Figure 105 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 106 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-user, 2023-2033 (US$ Million, AGR %)
Figure 107 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by End-user, 2023 & 2033 (%)
Figure 108 Japan AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 109 China AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 110 India AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 111 Australia AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 112 South Korea AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 113 Rest of Asia AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 114 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
Figure 115 Latin America AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 116 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 117 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
Figure 118 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Components, 2023-2033 (US$ Million, AGR %)
Figure 119 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Components, 2023 & 2033 (%)
Figure 120 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 121 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Application, 2023 & 2033 (%)
Figure 122 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR %)
Figure 123 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 124 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-user, 2023-2033 (US$ Million, AGR %)
Figure 125 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by End-user, 2023 & 2033 (%)
Figure 126 Brazil AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 127 Mexico AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 128 Argentina AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 129 Rest of Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 130 MEA AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
Figure 131 MEA AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 132 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 133 MEA AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
Figure 134 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Components, 2023-2033 (US$ Million, AGR %)
Figure 135 MEA AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Components, 2023 & 2033 (%)
Figure 136 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 137 MEA AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Application, 2023 & 2033 (%)
Figure 138 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR %)
Figure 139 MEA AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 140 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-user, 2023-2033 (US$ Million, AGR %)
Figure 141 MEA AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by End-user, 2023 & 2033 (%)
Figure 142 GCC AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 143 South Africa AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 144 Rest of MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 145 AI-Enabled Drug Discovery and Clinical Trials Market: Company Share Analysis, 2022
Figure 146 IBM: Net Revenue, 2019-2022 (US$ Million, AGR%)
Figure 147 IBM: R&D, 2019-2022 (US$ Million, AGR%)
Figure 148 IBM: Regional Market Shares, 2022
Figure 149 Novartis: Net Revenue, 2020-2022 (US$ Million, AGR%)
Figure 150 Merck: Net Revenue, 2019-2021 (US$ million, AGR %)
Figure 151 Net Revenue, 2019-2021 (US$ million, AGR %)

Companies Mentioned

  • AbbVie Inc.
  • Exscientia
  • GNS Healthcare
  • IBM Watson
  • Merck & Co., Inc.
  • Novartis AG
  • PathAI
  • Saama Technologies
  • Unlearn.AI, Inc.
  • Abbott Laboratories
  • AbbVie
  • Agilent
  • AiRXOS
  • Amazon Web Services (AWS)
  • AmerisourceBergen Corporation
  • AstraZeneca
  • Atomwise
  • Bee4sense
  • Benevolent AI
  • Berg Health
  • BIOAGE
  • Biofourmis
  • Biogenomix
  • BioSymetrics
  • BioVac Institute
  • BlackThorn Therapeutics
  • BlueDot
  • Brain+
  • Bristol-Myers Squibb
  • Butterfly Network
  • Carlyle Investment Management LLC
  • Cerebras Systems
  • Chronicled
  • Clinerion
  • Cloud Pharmaceuticals
  • ConcertAI
  • Cyclica
  • Datavant
  • Deep 6 AI
  • Deep Genomics
  • Deep Pharma
  • Evidation Health
  • Evotec
  • Exscientia
  • Exscientia plc
  • Facio Therapies
  • G42 Healthcare
  • GE Aviation
  • Genethon
  • Genlantis Pharma
  • Genmab
  • GNS
  • Grifols
  • GSK
  • GTN
  • HealtheLife
  • Healx
  • Ibn Sina
  • Iktos
  • Inception Therapeutics
  • Insilico Medicine
  • Insitro
  • Institut de la Vision
  • Institut Imagine
  • ION Solutions
  • Janssen Pharmaceutical
  • Johnson & Johnson
  • Ksilink
  • Lantern Pharma
  • Lunaphore Technologies
  • Medidata Solutions
  • MediLedger Network
  • Medtronic
  • Mendel.AIi
  • Merck Research Laboratories
  • Microsoft
  • Mind the Byte
  • MindPeers
  • Mindstrong
  • NanoString Technologies
  • Niramai
  • Novartis
  • Numedii
  • Nuritas
  • OncoImmunity
  • Oncora Medical
  • OneThree Biotech
  • Owkin
  • PathAI
  • Pear Therapeutics
  • Pfizer
  • PharmaLex Holding GmbHBigHat Biosciences
  • PT Bio Farma
  • Recursion Pharmaceuticals
  • Roche
  • Saama Technologies
  • Salamandra Zone
  • Science 37
  • SemanticMD
  • Sensorion
  • Servier
  • Sight Machine
  • Sigtuple
  • Spimeg
  • Summit Clinical Research
  • Symphony Health
  • Takeda
  • Tempus
  • Truven Health Analytics
  • Veeva Systems
  • Australian Government
  • Brazil Government
  • Cedars-Sinai Medical Center
  • Charité - Universitätsmedizin Berlin
  • Clinical Trials Center Cologne (CTCC)
  • Colombia Government
  • Columbia University
  • Council for Scientific and Industrial Research (CSIR)
  • Department of Science and Technology
  • Duke University
  • European Medicines Agency (EMA)
  • Food and Drug Administration (US FDA)
  • French Government
  • Heidelberg University Hospital
  • Indonesian Government
  • King Abdullah University of Science and Technology (KAUST)
  • Malaysian Government
  • MaRS Discovery District
  • Memorial Sloan-Kettering Cancer Center
  • Monash University of Australia
  • Mount Sinai Health System.
  • National Center for Genetic Engineering and Biotechnology (BIOTEC)
  • National Centre for Mathematical Modelling (NCMM)
  • Ontario Centres of Excellence
  • Philippine Government
  • Qatar Computing Research Institute (QCRI)
  • Russian Government
  • Saudi Government
  • SLAS Europe Conference and Exhibition
  • South African Medical Research Council (SAMRC)
  • South Korean Government
  • Technology Innovation Agency (TIA)
  • Thailand's National Innovation Agency
  • University of Bonn
  • University of California
  • University of Michigan
  • University of Texas MD Anderson Cancer Center
  • University of San Francisco
  • World Health Organization (WHO)

Related Topics

Related Reports

Generative Artificial Intelligence (AI) in Drug Discovery Global Market Report 2024 - Product Image

Generative Artificial Intelligence (AI) in Drug Discovery Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Artificial Intelligence (AI) In Drug Discovery - Market Insight, Competitive Landscape And Market Forecast - 2030 - Product Image

Artificial Intelligence (AI) In Drug Discovery - Market Insight, Competitive Landscape And Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Artificial Intelligence (AI) in Drug Discovery - Global Strategic Business Report - Product Image

Artificial Intelligence (AI) in Drug Discovery - Global Strategic Business Report

  • Report
  • 219 Pages
  • Global
From
Artificial Intelligence (AI) in Drug Discovery Global Market Report 2024 - Product Image

Artificial Intelligence (AI) in Drug Discovery Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Artificial Intelligence in Drug Discovery Market by Offering, Technology, Process, Application, Therapeutic Area, End User - Global Forecast 2025-2030 - Product Image

Artificial Intelligence in Drug Discovery Market by Offering, Technology, Process, Application, Therapeutic Area, End User - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.